Christof Vulsteke completed his internal medicine and medical oncology fellowship in 2013 and obtained his PhD degree in 2015 with the thesis entitled 'the impact of germline genetic variability on chemotherapy induced toxicity and outcome in early breast cancer patients' at the University of Antwerp.
Christof Vulsteke is head of the Integrated Cancer Center Ghent and Head of the Clinical Trial Unit Oncology.
Christof Vulsteke is Guest Professor at the University of Antwerp (Research Group MIPRO, Research Unit CORE)
Statute & functions
Bijzonder academisch personeel
- visiting professor